Applied Therapeutics Says FDA Unable To Approve Govorestat NDA Due To Clinical Deficiencies; Expects To Submit An NDA Early In Q1 Of 2025
Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application For Govorestat For Classic Galactosemia
TC BioPharm Plc Files For Mixed Shelf Of Up To $100M
Wednesday Ends With Index Decline | Wall Street Today
Titan Pharmaceuticals Gets Non-Compliance Notice From Nasdaq
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
AIM ImmunoTech Refutes Activist Group's False And Misleading Claims; Urges Shareholders To Safeguard Aim By Voting "For" All Of The Board's Incumbent Candidates And Discarding Any Proxy Materials Received From The Activist Group
FDA Investigating Safety Risks of Bluebird's Skysona
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
Dow Falls Over 100 Points; US Crude Oil Stocks Decline
Mizuho Maintains Outperform on Adaptimmune Therapeutics, Lowers Price Target to $1.5
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Why Is BeiGene Stock Trading Higher On Wednesday?
Edgewise Therapeutics Analyst Ratings
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript Summary
FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
US Stocks Mixed; Economy Grows By 2.8% In Q3
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul